Elemene oral emulsion

The results of in vitro tests showed that this product had an inhibitory effect on the growth of both gastric cancer cell lines 801 and 803; the results of in vivo animal tests showed that this product had a prolonging effect on the average survival time of tumor-bearing rats inoculated with W256 carcinosarcoma in the gastric muscle layer.

The main ingredient of this product is a mixture of β-, γ-, and δ-elemene.

This product is a milky white uniform emulsion.

Used for adjuvant treatment of esophageal cancer, gastric cancer and to improve symptoms.

Oral administration, 20 ml each time, three times a day. Swallow in small sips on an empty stomach before meals. A course of treatment is 4-8 weeks. Or follow the doctor's advice.

There may be digestive tract reactions, such as nausea, vomiting, diarrhea, etc., and occasionally loss of appetite, decreased hemoglobin, decreased leukocytes, etc. Adverse reactions are mostly mild and do not affect treatment.

It is contraindicated for patients with high fever.

Precautions for children: The use of this drug in children is not yet clear. Precautions for pregnancy and lactation: Not recommended. Precautions for the elderly: The use of this drug in elderly patients is the same as that in adults.

According to literature reports, this product may have a certain synergistic effect with certain chemotherapy drugs such as VP-16, CF, fluorouracil, etc. Animal experiments have shown that this product can enhance the central inhibitory effect of hypnotic drugs.

Keep in a dark and airtight container in a cool place (not exceeding 20°C) to prevent freezing.

20ml:0.2g

36 months

Dalian Huali Jingang Pharmaceutical Co., Ltd.

• Founded in:

  1992-12-03

• Address:

  No. 8 Chengen Street, Jinzhou District, Dalian City, Liaoning Province

• Tax NO.:

  912102136048258717

• Registered Funds:

  8.88 million yuan

• Website:

  Log in to view

• Email:

  Log in to view